| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Rey-Giraud Agnes is a Director at GDRX. Recent filings cover 0 purchases and 6 sales.
Our model assigns Rey-Giraud Agnes a strong insider score of 81/100, based on 6 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +74.2%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 | GDRX Goodrx Holdings, Inc. | Director | Sell | 25,000 | $45.01 | $1,125,193.75 | -100% | -18.2% | -86.9% | |
| Sep 7, 2021 | GDRX Goodrx Holdings, Inc. | Director | Sell | 54,370 | $41.56 | $2,259,682.44 | -100% | -7.4% | -85.2% | |
| Apr 1, 2021 | GDRX Goodrx Holdings, Inc. | Director | Sell | 25,000 | $40.01 | $1,000,305.00 | -100% | -7.7% | -49.6% | |
| Mar 22, 2021 | GDRX Goodrx Holdings, Inc. | Director | Sell | 25,000 | $36.38 | $909,602.50 | -100% | +1.2% | -52.6% |